 Books & Catalogues
The art of scientific writing
Sirius Analytical Instruments
Sigma-Aldrich
Kits for nucleic acid purification
Dionex Corporation/LC Packings
Spectroscopy sampling accessories and supplies
Practical enzymology
The Laboratory Informatics Capabilities
Evolutionary Methods in Biotechnology
Applied Biosystems
HPLC, GC, SPE and Flash Separation
Millipore
National Institute of Standards and Technology
Argonaut Technologie
Chiral HPLC of Antimalarial Drugs
Columns and Accessories for LC and LC/MS
Business News
QIAGEN
Hybrigenics S.A. optimizes mapping of protein interactions
First chip-based test gains CE mark
Roche and Glycart cooparate
US patent for computer-aided screening method
News in Brief 2
Assay system proves its worth for gut permeability
News in Brief 1
Faster detection of genetic variations
Two partnerships for Lion bioscience
NMR magnet is more powerful but just as compact
For young European investigators
5 million venture funding for siRNA therapeutics program
Mainline chooses TurboWorx
Invitrogen research kits for Tecan instruments
Regulatory Affairs
Documents from the FDA 2004
Gene transfer research
Center for Biologic-Evaluation and Research
Updates list
EudraCT website
Stability Testing
CPMP Guideline
Analytical Methods
New Legislation Dates
Road Map Until 2010
Twelfth Law Amending the Medicines Act
Control of Impurities in Pharmacopoeial Substances
EDQM as Official Control Authority Batch Release
Business News
ProteoGenix and Bruker Daltonics collaborate
Biotechnology Forum
Mission of EAPB:
Mission of EAPB:
Regulatory Affairs
“Inactive Ingredients Database”
Orphan Medicinal Products
ICH Q1E Guidance
The Efficacy Working Party
Fast track development program guidance
Product Information Templates
Statement on Creutzfeldt-Jakob disease
DIA Meeting 2004
UK MHRA: How to submit a clinical trial authorisation (CTA)
Guidance for Industry
CDER and CBER
EAPB Biotechnology Forum
Mission of EAPB
Mission of EAPB
Drug Discovery
Revolutionizing Drug Discovery
with High-Throughput Microarray Analysis
Regulatory Affairs
FDA
New website
Fast Track Designation Performance
Center for Biologic Evaluation and Research
“Common Technical Document, CTD”
European Union and EEA
Comparability of Biologic Products
Plasma Master File (PMF)
Safety Working Party (SWP)
Quality Review Documents
Training Programme
Recommended Dates for CentralisedProcedures
The 12th amendment of the German Drug Law
New acting Head of BfArM
Drugs @ FDA
BSE in USA
EudraLex in the nine new EU Languages
FDA`s Center for Biologigs
Therapeutic Products Directorate
Orphan Designation
Orphan Medicinal Products
The European Directorate
The Future of EU Pharmaceutical Guidelines
Electronic Submission of adverse reaction reports
Microarrays
DNA Microarrays –A Novel Path Towards Individualized Medicine
Biotech regions
Successful Investments in the U.S.
Girindus in Biotech Cluster of “Cincinnati USA”
Regulatory Affairs
Target-based Anticancer Therapeutics – Scientific & Regulatory Aspects
Microarrays
An Array of Advantages – 60-mer Oligonucleotides Come Out Ahead
Manually Operated vs. Automated Protein Microarray Processing
– a Comparison
Bioinformatics
Protein Research Accelerated by Improved
Data Management
Mass Spectrometry
Mass Spectrometry
In Analytical Chemistry
Microarrays
High Throughput Platforms for Microarrays:
a Pre-requisite for Diagnostic Applications
Lab-on-a-Chip
Polymer based Microarray and
Microfluidic Platforms
Tarteting
Identifying Drug Targets with SuperSAGE
Bioinformatics
The Path of Validation
Lab-on-a-Chip
Quality Control of Protein Pharmaceuticals
with Microfluidic Technology
Kits & Reagents
A New Lipofection Reagent For Co-Transfection of DNA and siRNA
Automation
Quantification of Protein-Protein Interactions by Fluorescence
Drug Development
Simulation of drug behavior
Imaging
High-Content Analysis of Camptothecin-induced Apoptosis using Laser Scanning Cytometry
Drug Development
New Drug Development:
The Importance of a Global Strategic Management Approach
Optimization in Drug Discovery Process
Microwave-Assisted Organic Synthesis –
The need for Scale Up
|
